Login to Your Account



Vote Against Combidex Hurts Cytogen, Advanced Magnetics

By Aaron Lorenzo


Friday, March 4, 2005
WASHINGTON - Stock values plummeted in the companies behind the molecular imaging agent Combidex (ferumoxtran-10) following a negative FDA panel vote. That thumbs-down damaged Advanced Magnetics Inc.'s shares by two-thirds and halved Cytogen Corp.'s stock. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription